Bristol-Myers Squibb to Participate in the 37th Annual J.P. Morgan Healthcare Conference
January 05 2019 - 11:07AM
Business Wire
Bristol-Myers Squibb Company (NYSE: BMY) today announced that
Giovanni Caforio, M.D., chairman and chief executive officer, will
join Mark Alles, chairman and chief executive officer of Celgene,
for a fireside chat at the 37th Annual J.P. Morgan Healthcare
Conference at 7:30 a.m. PT (10:30 a.m. ET) on Monday, January 7,
2019 at the Westin St. Francis in San Francisco.
Investors and the general public are invited to listen to a live
webcast of the presentation at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
presentation will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190105005008/en/
Media:Carrie
Fernandez609-252-5222carrie.fernandez@bms.comorLaura
Hortas609-240-7025laura.hortas@bms.comInvestors:John
Elicker609-252-4611john.elicker@bms.comorTim
Power609-252-7509timothy.power@bms.comorBill
Szablewski609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024